The once-daily fixed-dose combination of olodaterol and tiotropium in the management of COPD: current evidence and future prospects

Long-acting bronchodilators are the cornerstone of pharmacologic treatment of chronic obstructive pulmonary disease (COPD). Spiolto(®) or Stiolto(®) is a fixed-dose combination (FDC) containing two long-acting bronchodilators, the long-acting muscarinic receptor antagonist tiotropium (TIO) and the l...

Descripción completa

Detalles Bibliográficos
Autores principales: Derom, Eric, Brusselle, Guy G., Joos, Guy F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475840/
https://www.ncbi.nlm.nih.gov/pubmed/31002020
http://dx.doi.org/10.1177/1753466619843426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475840/
https://www.ncbi.nlm.nih.gov/pubmed/31002020
http://dx.doi.org/10.1177/1753466619843426

Ejemplares similares